title: Long QT syndrome and life-threatening anaphylaxis: Is epinephrine safe?
authors: Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: white.jennifer1@mayo.edu.
authors: Jennifer L
authors: JL
authors: White
authors: Division of Pediatric Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
authors: Robert J
authors: RJ
authors: Kahoud
authors: Division of Allergic Diseases, Mayo Clinic, Rochester, Minnesota.
authors: James T C
authors: JT
authors: Li
authors: Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota.
authors: Ronna L
authors: RL
authors: Campbell
authors: Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.
authors: Michael J
authors: MJ
authors: Ackerman
mesh_terms: D000707:Anaphylaxis / Q000188:drug therapy*; D000075224:Cardiac Conduction System Disease / Q000188:drug therapy; D002675:Child, Preschool; D004837:Epinephrine / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy*
chemical_list: D004837:Epinephrine